Our contract immunology research team is always looking for a new challenge. So when a customer proposed a project that involved differentiating monocytes into osteoclasts, we said, “Why not!” Fun in the Lab with Monocytes Osteoclasts are macrophages found in bone and are highly specialized myeloid cells that break down and resorb bone tissue, important…
What’s in This Vial? It’s a question we’re happy to hear from inquisitive customers, and one that’s important for all researchers to know the answer to. For years we have been answering customer questions about the pathogen testing that we conduct on our immune cell products and donors, so we’re answering those FAQs here for…
This was our first year attending the Cell Symposia Hallmarks of Cancer event held here in Seattle — and boy was it informative! The event brought together some of the world’s leading cancer researchers and oncologists to share the latest from their research and practices. We got to hear from the likes of Philip Greenburg,…
Have you ever spent weeks or months pursuing a mysterious artifact in your culture only to discover that the cause was a reagent or culture media contaminated with bacterial endotoxin? You’re not alone. Continue reading for a cautionary tale on endotoxin contamination. Detecting a Problem: Clueing in on Endotoxin Contamination We encountered an endotoxin contamination…
New to our ever-expanding immune cell inventory is a CMV-Specific CD4+ T Cell Line, available in large batches of 1–2M cells/vial. Our CMV-specific T cells have been extremely popular among our customers for years, but have only been available as CD8+ cell lines until now. As immunologists, we naturally think of CD8+ T cells when…
MMRF Funds Critical Research Relying on Patients Multiple Myeloma Research Foundation + NexImmune Partnership MMRF’s mission to advance new multiple myeloma therapy into clinical trials for MM patients includes a new formal partnership with NexImmune. A world leader in cancer research, the MMRF’s investment will advance NexImmune’s promising immuno oncology drug candidate NEXI-002 and support…
As a buyer of human and animal immune cell products, you trust that your biomaterials will be handled with care and precision throughout the collection, processing, characterization, and cryopreservation processes. We understand how immensely important cell quality is to the efficacy and timeliness of your research efforts, which is why we are completely transparent with…
T-Scan: A genome-wide method for the systematic discovery of T cell epitopes Kula et al. describe a new method for discovering T cell epitopes that does not require the culture of T cells and allows for precise mapping of T cells to the peptides they recognize. Cellero Cells Used: PBMC Inhibitory effect of Acer tegmentosum…
Do you have a pesky little habit you just can’t kick? One that’s hard to ignore because you’re reminded of it everywhere you turn? Your friends are doing it, your colleagues are doing it, even your parents are doing it! (If they are research scientists.) We are, of course, talking about the habit of focusing…
Immune therapy to fight cancer specifically programs a patient’s own immune system to target & destroy invading disease cells. The ability of immunotherapy to more strategically combat cancer than general cancer treatments do is only now being fully understood. And as scientists excitedly recognize immunotherapies’ potential is far greater than first imagined, donor blood cells…